A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database
BackgroundTirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for chronic weight management in adults with obesity or overweight as an adjunct to a reduced-calorie diet and increased physical activity. However,...
Saved in:
| Hovedforfatter: | |
|---|---|
| Format: | Bog |
| Udgivet: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
| Fag: | |
| Online adgang: | Connect to this object online. |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|
Internet
Connect to this object online.3rd Floor Main Library
| Klassifikationsnummer: |
A1234.567 |
|---|---|
| Kopi 1 | Tilgængelig |